Real possibility but these studies are always quite broad, and they would really have to see absolutely no affect described by the non placebo participants to arrive at a failure.
As always it would not just be bad for CANN but bad for the whole industry as this is probably one of the easier ones to get OTC approval for.
Real possibility but these studies are always quite broad, and...
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.12M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CAN (ASX) Chart |
Day chart unavailable